Genentech signs neurodegenerative deal with UCSF
This article was originally published in Scrip
Executive Summary
Genentech is to provide funding and research expertise in neuroscience to the University of California, San Francisco (UCSF) and will work with the university to identify small molecules for neurodegenerative diseases.